9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Drug-drug interactions of non-vitamin K oral anticoagulants.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The approval of non-vitamin K oral anticoagulants (NOACs) as antithrombotic alternatives to vitamin K antagonists (VKAs) has changed clinical practice. However, the efficacy and safety of the four most commonly used NOACs (dabigatran, rivaroxaban, apixaban and edoxaban) might be compromised by co-administration of other medications used for various major comorbidities. Dose adjustment of the NOACs may be needed to avert cases of concomitant medication affecting NOACs absorption, metabolism and coagulation. Areas covered: This review summarizes the current knowledge regarding drug-drug interactions of NOACs in order to guide health professionals regarding the dose modification required if the NOACs are co-administered with other medication with potential significant interactions. The data were acquired from searches of PubMed and also from the NOAC reports to the European Medicines Agency and Food and Drug Administration Agency. Expert opinion: Most of the studies in this field have been organized by pharmaceutical companies. Independent research and registries will provide more information in the near future about the drug-drug interactions of NOACs. P-glycoprotein transporter and cytochrome P450 enzyme complexes appear to be the main pathways where the most drug-drug interactions with NOACs occur.

          Related collections

          Author and article information

          Journal
          Expert Opin Drug Metab Toxicol
          Expert opinion on drug metabolism & toxicology
          Informa UK Limited
          1744-7607
          1742-5255
          Dec 2016
          : 12
          : 12
          Affiliations
          [1 ] a University of Birmingham Institute of Cardiovascular Sciences, City Hospital , Birmingham , UK.
          Article
          10.1080/17425255.2016.1225037
          27535163
          9853183e-6f8d-4d83-bcc7-d13f5e4ee1d3
          History

          Non-vitamin K oral anticoagulants,P-glycoprotein,apixaban,cytochrome P450(CYP),dabigatran,drug-drug interactions,edoxaban,rivaroxaban

          Comments

          Comment on this article